COVID-19 LNMA: COVID-19 living network meta-analysis: Drugs, antibodies, and cellular therapies for treatment and prophylaxis against COVID-19

ABSTRACT

This website provides up-to-date information about the use of pharmaceuticals, antiviral antibodies, and blood products in treatment and prevention of COVID-19. The evidence presented is the joint effort of an international group of researchers. The core group is based at McMaster University, and collaborates closely with the Magic Evidence Ecosystem Foundation and The BMJ. We also work independently of, but in collaboration with, the World Health Organization. This work is partially funded by the Canadian Institutes of Health Research operating grants VR4-172738 and MM1-174897